Our hypothesis, built on in vivo and clinical evidence was that pathways with known association to obesity and insulin resistance; namely insulin signaling, TNFα and LPS signaling and adipose tissue signaling resulting in the release of chemokines, should be effected by our list of associated proteins. The gene discussed is INS; the disease is obesity disorder.